Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gipson, Debbie S., Trachtman, Howard, Kaskel, Frederick J., Radeva, Milena K., Gassman, Jennifer, Greene, Tom H., Moxey-Mims, Marva M., Hogg, Ronald J., Watkins, Sandra L., Fine, Richard N., Middleton, John P., Vehaskari, V. M., Hogan, Susan L., Vento, Suzzane, Flynn, Patti A., Powell, Leslie M., McMahan, June L., Siegel, Norman, Friedman, Aaron L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/
https://ncbi.nlm.nih.gov/pubmed/21178977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items